Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada
- PMID: 19436079
- PMCID: PMC2682153
- DOI: 10.1136/bmj.b1673
Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada
Abstract
Objective: To investigate whether the 1998 government policy for mandatory fortification of flour and pasta products with folate was followed by a reduction in the prevalence of severe congenital heart defects.
Design: Time trend analysis.
Setting: Province of Quebec, Canada.
Participants: Infants born in 1990-2005 identified with severe congenital heart defects (tetralogy of Fallot, endocardial cushion defects, univentricular hearts, truncus arteriosus, or transposition complexes) in Quebec administrative databases.
Methods: Data analysed in two time periods (before and after fortification). Birth prevalence measured annually as infants (live and stillbirths) with severe congenital heart defects per 1000 births in Quebec. Changes in the birth prevalence from the period before to the period after fortification were estimated with Poisson regression.
Results: Among the 1, 324,440 births in Quebec in 1990-2005 there were 2083 infants born with severe congenital heart defects, corresponding to an average birth prevalence of 1.57/1000 births. Time trend analysis showed no change in the birth prevalence of severe birth defects in the nine years before fortification (rate ratio 1.01, 95% confidence interval 0.99 to 1.03), while in the seven years after fortification there was a significant 6% decrease per year (0.94, 0.90 to 0.97).
Conclusions: Public health measures to increase folic acid intake were followed by a decrease in the birth prevalence of severe congenital heart defects. These findings support the hypothesis that folic acid has a preventive effect on heart defects.
Conflict of interest statement
Competing interests: None declared.
Figures

Comment in
-
Folic acid fortification and congenital heart disease.BMJ. 2009 May 12;338:b1144. doi: 10.1136/bmj.b1144. BMJ. 2009. PMID: 19436078 No abstract available.
References
-
- Rieder MJ. Prevention of neural tube defects with periconceptional folic acid. Clin Perinatol 1994;21:483-503. - PubMed
-
- Pitkin RM. Folate and neural tube defects. Am J Clin Nutr 2007;85:285-8S. - PubMed
-
- De Wals P, Tairou F, Van Allen MI, Uh SH, Lowry RB, Sibbald B, et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med 2007;357:135-42. - PubMed
-
- Recommendations on the use of folic acid for the prevention of neural tube defects. J SOGC 1993;(suppl):41-6.
-
- Bureau of Food Regulatory, International and Interagency Affairs, Health C. Regulatory impact analysis statement. Canada Gazette Part II 1998;132(24):3029-33.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical